La nueva Vueling se estrena con 40.000 viajeros y 263 vuelos
July 10, 2009 | In: General
La nueva Vueling, fruto de la fusión de Vueling y Clickair, se estrenará hoy con 263 vuelos, 71 rutas y más de 40.000 pasajeros, de los cuales el 70% operarán desde el aeropuerto de Barcelona El Prat, según informó la aerolínea presidida por Josep Piqué.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.
This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx.
The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.
Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks | Media | China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported.
JERUSALÉN (AFP) – Dos militares israelíes y al menos dos combatientes palestinos murieron el viernes en un tiroteo cerca de la franja de Gaza, en momentos en que el primer ministro Benjamin Netanyahu consultaba a sus ministros para responder a las crecientes presiones de Washington sobre la colonización.
The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010.
“Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering.
LONDRES (AFP) – Los empleados del Royal Mail británico anunciaron este miércoles que volverán a la huelga a partir del jueves para protestar por sus salarios, sus empleos y la modernización de la empresa, tras el fracaso este miércoles de la última ronda de negociaciones con la dirección.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.
Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.
For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro.
Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks | Media | China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”. “We are undertaking a thorough review of our service andtaking all necessary steps to fix any problems with ourresults.
PARÍS (AFP) – La hora de tomar decisiones y de comprometerse con objetivos cifrados ha llegado para los 192 países que se reunirán a partir del lunes en Copenhague con el propósito de lograr un acuerdo que permita frenar el calentamiento climático y adaptarse a sus inevitables consecuencias.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.
KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.
KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.
Reuters determines astros game used Diary Desk houston astros reasons Germany, tel +49 30 2888 5000, or e-mail , or via Reuters Messaging at NOTE: The inclusion of diary items does not necessarily mean that Reuters will file a story based on the event.. Securian Financial Group Eyes Expanded Distribution With Membership in BrokerGroupST. PAUL, Minn., June 23 /PRNewswire/ — Securian Financial Group was admittedinto the Association of Financial Institution Brokers (AFIB) as an affiliatemember. Securian’s subsidiaries provide insurance and loan protection products andservices to financial institutions. AFIB is a nationwide network of brokersand providers that market to financial institutions. Providers must apply foraffiliate membership in the AFIB and be accepted by a majority vote of thebroker membership. “AFIB is the premier association of financial institution brokers and providesopportunities to build relationships with people who are important to ourbusiness,” said John Gibbons, managing director of Securian’s financialinstitution sales and marketing unit.
“The collaborative environment that AFIBhas created strengthens the industry and helps providers like Securian growdistribution.”According to its web site, AFIB was formed to provide networking opportunitiesamong brokers and providers and to represent the industry in dealings withgovernmental bodies astrosdaily . Securian is one of 25 product and service providers thatbelong to the organization.Securian Financial Group and its affiliates have served financial institutionsfor over 50 years, providing insurance, debt protection, loan documents, andmarketing services to more than 4,000 financial institutions across the UnitedStates jeff bagwell . SOURCESecurian Financial Group, Inc.Maggie Jensen, APR of Securian Financial Group, +1-651-665-7558 koby clemens . – –Berlin Newsroom +49 30 2888-5000 Stocks | Bonds Stocks Bonds lance berkman .
PENNSAUKEN, N.J., June 23 /PRNewswire/ — Airborne Systems Group, a companyspecializing in aerial delivery, rescue and survival equipment, andengineering services, announced that Richard J baseball tickets . Smallwood has been namedExecutive Vice President of Customer Business for the company lance berkman autographed baseball . He will operateat Group level as a member of the Senior Management Team and will beresponsible for all sales and marketing activity worldwide lance berkman wiki . His primary focuswill be to continue the growth of the company by leveraging the products andoverall capabilities while continuing to improve the company’s customer focus.(Logo: http://)”Richard brings an exceptional background of global sales and marketingexperience with some of the world’s most respected aerospace companies,” ElekPuskas, CEO said in making the announcement houston astros . “We are confident that Richard’sexpertise and leadership skills will continue to position Airborne Systems asthe preeminent market leader in the design and manufacture of parachutes andrelated products, while maintaining our aggressive growth rate,” he added.Richard has a wealth of experience in international sales and marketing gainedmainly in the aerospace and marine industry.
He spent 22 years withRolls-Royce plc holding a number of senior executive positions includingSenior Vice President, Airlines and Business Director, Marine Systems brad ausmus wife . Duringhis time at Rolls-Royce he also spent three years based in Germany as ManagingDirector, Business for the joint venture BMW Rolls jeff bagwell . Prior to Rolls-Royce, hewas with BAE Systems where he worked on both civil and military aircraftprogrammes koby clemens . He has an honours degree in Production Engineering from AstonUniversity and an MBA from Cranfield School of Management (University).About Airborne SystemsAirborne Systems is a world leader in the design, development, and manufactureof best-of-class parachutes for military, personnel, and cargo systems, spaceand air vehicle recovery systems, and deceleration systems forhigh-performance aircraft . The company also provides airbags, and weaponsdelivery systems.
LOS ANGELES (AFP) – La diva estadounidense del soul pop Beyoncé ganó el premio Grammy a la Canción del Año con “Single Ladies (Put a Ring on It)” en la 52 ceremonia de entrega de los galardones musicales que se lleva a cabo este domingo en Los Angeles.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction.
The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.
Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, .
MELBOURNE, Australia (AFP) – Los ‘números uno’ del tenis mundial, el suizo Roger Federer y la estadounidense Serena Williams, pasaron este miércoles a las semifinales del Abierto de Australia, al derrotar al ruso Nikolay Davydenko y a la bielorrusa Victoria Azarenka, mientras que el serbio Novak Djokovic cayó ante el francés Jo-Wilfried Tsonga.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement.
Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization.
News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements.
Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th.
SAINT ANDREWS, Reino Unido (AFP) – Los ministros de Finanzas de los países del G20, reunidos este sábado en Saint Andrews (Escocia), fijaron un calendario para la vigilancia mutua de sus políticas económicas, según el comunicado final.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.
KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.
MADRID (AFP) – El centrocampista Guti, del Real Madrid, volvió este miércoles a entrenar con su equipo tras más de dos meses de ausencia a causa de las lesiones y de su conflicto con el entrenador, Manuel Pellegrini, tras la humillante derrota en octubre contra el Alcorcón en la Copa del Rey.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction.
The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.
Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext.
ROMA (AFP) – Las cenizas del escritor italiano Dino Buzzati (1906-1972), autor de ‘El desierto de los Tártaros’, serán dispersadas en el macizo de los Dolomitas, en virtud de una nueva ley votada en la región de Venecia, que autoriza la dispersión de cenizas funerarias en la naturaleza.
Shares in PKN rose 2.2 percent late in the session, in linewith the wider market. The stock has gained 9.4 percent so farthis year, outperforming a 7.7 percent rise of Warsaw’s mainWIG20 index .WIG20 (Editing by David Jones). BEIJING, June 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd.(NYSE Amex: SVA), a leading developer and provider of vaccines in China,announced today that the Company received the first order in China to supplyits influenza A (H1N1) vaccine to the Beijing government. The initial orderconsists of 4 million doses and is expected to be delivered by the end ofSeptember.This order will be administered to 2 million people in the highrisk group.Additional orders are expected beginning in October and, intotal,Sinovac expects to supply approximately 10 million doses to the Beijinggovernment.The 10 million doses will be administered to 5 million people inBeijing.On June 14, 2009, Sinovac completed construction of the H1N1 virus seedbank necessary to produce a virus antigen and commenced production of thefirst batch of H1N1 vaccine.Sinovac expects to complete production of thefirst batch by the end of July.Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, “Weare organizing and coordinating all personnel and resources to produce theH1N1 vaccine, as we have almost completed the production of our seasonalinfluenza vaccine.With the support and instruction of the relevantgovernment and health authorities, Sinovac will fully utilize its provendevelopment and production abilities from both the H5N1 vaccine and seasonalflu vaccine to ensure the efficient production of the H1N1 vaccine.We areworking closely with authorities in order to contribute to the prevention andcontrol of the H1N1 epidemic situation.”About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases.
Sinovac’s vaccineproducts include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A andB), and Anflu(R) (influenza). Panflu(TM), Sinovac’s pandemic influenza vaccine(H5N1), has already been approved for government stockpiling.Sinovac isdeveloping vaccines for enterovirus 71, universal pandemic influenza, Japaneseencephalitis vaccine, and human rabies vaccine.Its wholly owned subsidiary,Tangshan Yian, is conducting field trials for independently developedinactivated animal rabies vaccines.Safe Harbor StatementThis announcement contains forward-looking statements. These statementsare made under the “safe harbor” provisions of the U.S Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as “will,” “expects,” “anticipates,”"future,” “intends,” “plans,” “believes,” “estimates” and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements. Statements that are nothistorical facts, including statements about Sinovac’s beliefs andexpectations, are forward-looking statements.
Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement. Sinovac does not undertake any obligation to updateany forward-looking statement, except as required under applicable law.For more information, please contact: Helen G Yang Sinovac Biotech Ltd. Tel: +86-10-8289-0088 x9871 Fax: +86-10-6296-6910 Email: Investors: Amy Glynn/Sara Pellegrino The Ruth Group Tel: +1-646-536-7023/7002 Email: Media: Janine McCargo The Ruth Group Tel: +1-656-536-7033 Email: SOURCESinovac Biotech Ltd.Helen G.
PARÍS (AFP) – El filme ‘Huacho’, del chileno Alejandro Fernández Almendras, tiene su estreno mundial en salas de cine el miércoles en Francia, adonde llega tras ser galardonado en varios festivales, entre ellos el de Viña del Mar, que la coronó como Mejor Película.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.
The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx.
The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.
PUERTO PRÍNCIPE (AFP) – Un equipo internacional de socorristas rescató este sábado con vida a un hombre en la capital haitiana, quien pasó 11 días bajo los escombros tras el terremoto que devastó a ese país caribeño.
(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement.
Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization.
News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S.
Monthly returns are then linked geometrically toproduce quarterly and annual total return performance figures. Sprint Nextel is widely recognized fordeveloping, engineering and deploying innovative technologies, including twowireless networks serving almost 49 million customers at the end of the secondquarter of 2009; industry-leading mobile data services; instant national andinternational push-to-talk capabilities; and a global Tier 1 Internet backbone.The company`s customer-focused strategy has led to improved first callresolution and customer care satisfaction scores For more information, visit. The standard report covers recent year pricedata and features regional trade statistics. The company is headquartered in Japan, with offices strategicallylocated throughout Europe, Asia and North America. “We are very excited about The Wider Scope of Arthroscopymeeting and extremely honored to have some of the leading minds in Knee, Hipand Shoulder arthroscopy scheduled to attend. automakers seek to reverse their fortunes and increase production of hybrids and introduce electric cars.
While recent developments,like electronic invoice automation, have offered hope, most “solutions” havebeen difficult to use, costly to manage and lacking all the right parts tomake for a front-to-back product. Bush.MIDDLE EASTObama managed to bring together for a three-way summit the Israeli prime minister, Benjamin Netanyahu, and Palestinian President Mohammed Abbas. WHOLESALE GAS PRICES PUMP UP PROFITS FOR SUPPLIERS According to consultants Energy Contract Company, profitmargins at gas suppliers are higher than at any time in the pastten years because the plunge in wholesale prices has not beenmatched by a drop in household bills. The recent financial crisis,coupled with the low predictions of growth in developed nations, hasgiven new appreciation to the potential growth in emerging economies. But an elimination of royalty fees would be difficult as software licenses are the lifeblood for the company which dominates the desktop computer software market.”If they remove the royalties then that poses big questions for a lot of Microsoft’s other business units.” said Geoff Blaber, an analyst at CCS Insight.
Thesurvey allows merchants to understand how each engine ranks in terms ofsize/volume, cost, return rates, and overall service. of read bandwidth and more than 500,000 read IOPS.The cards come in 160GB, 320GB and 640GB capacities. Average equivalent shares1 671.8666.4 1 %672.8 666.31 % NM = Not Meaningful 1 For 2009, amounts disclosed are diluted earnings per share. – IDG News Service\Paris BureauA French government agency has warned that measures should be taken to reduce everyday exposure to radio signals — even though, it said, there is no definitive proof that such signals have a negative effect on human health.The French Agency for Environmental and Occupational Health Safety conducted a review of around 3,500 studies and publications. NEW YORK, Oct 16 (Reuters) – North American shipments of replacementautomotive lead-acid batteries fell 1.36 percent from July, but climbed8.51 percent from year-ago figures, a U.S industry group said this week. The precious metal is also often bought as a hedge against adepreciation in the U.S currency. Each rocker is numberedas part of a limited edition of 1,700.
VARSOVIA (AFP) – - El museo del antiguo campo de concentración alemán de Auschwitz-Birkenau ha decidido integrarse plenamente en la red y ha creado su perfil en el portal social de internet Facebook, bajo el nombre ‘Auschwitz memorial’, informó este jueves el museo.
The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.
This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.
The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.
Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks | Media | China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”.
BOGOTÁ (AFP) – La aspiración de cinco ex rehenes de las FARC y del padre de uno de los 23 uniformados en poder de esa guerrilla de llegar al Congreso de Colombia en los comicios del domingo fue un gran fracaso, pues sólo uno lo logró.
The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010.
“Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology.
In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles.
Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation. Sales also tend to fluctuateyear on year, as specific exclusivities are gained and expire.
Fees and service charges on deposits decreased $363thousand as compared to the fourth quarter related mainly to declines inoverdraft fees of $271 thousand and declines of $122 thousand related to debitcard fees. Other non-interest income increased $825 thousand, or 98%, for thequarter primarily as a result of a one-time tax refund from the state ofWashington. Non-interest Expense:Non-interest expense for the three months ended March 31, 2009 was $20.6 millionas compared to $27.3 million for the quarter ended December 31, 2008 and $18.8million (excluding a goodwill impairment charge of $27 million) in the firstquarter of 2008. The Company continues to pursue various cost savingsinitiatives. While non-interest expense was down from the previous quarter, thedecrease of $6.7 million, or 25%, was principally due to a decrease inforeclosed real estate costs of $2.9 million, a decrease in salaries andemployee benefits of $1.6 million, and a decrease in impairment of premises andsecurities of $1.1 million. The efficiency ratio for the quarter ended March 31, 2008 was 101% as comparedto 138% in the prior quarter and 70%, excluding the goodwill impairment charge,for the quarter ended March 31, 2008. Income Taxes:As a result of the Company`s current going concern status as of December 31,2008, all tax benefits from operating losses in 2009 have been deferred and alldeferred taxes have been fully reserved.
The Company has not shown any taxbenefit for operating losses in the first quarter. If the Company is successfulin raising additional capital and future operating profitability is probable, itis likely the going concern status will be rescinded and the valuation reservefor deferred tax asset reversed, significantly enhancing the regulatory capitalratios of both the Bank and the Company. About AmericanWest Bancorporation:AmericanWest Bancorporation is a bank holding company whose principal subsidiaryis AmericanWest Bank which includes Far West Bank operating as an integrateddivision of AmericanWest Bank. AmericanWest Bank is a community bank with 58financial centers located in Washington, Northern Idaho and Utah. (2) Presented on a tax equivalent basis for tax exempt securities. Interest income includes loan fee income.(2) Tax-exempt securities income has been presented using a tax equivalent basis and an assumed tax rate of 34%.AmericanWest BancorporationPatrick J.
Rusnak, President and CEO, orKelly McPhee, Communications Manager, Copyright Business Wire 2009. BETHESDA, Md.–(Business Wire)–Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that it will sponsora conference call to discuss its financial results for the quarter ended March31, 2009. These results are expected to be disclosed on Thursday, May 7, 2009,after the capital markets close. The conference call will be hosted by senior management and will be held at 5:00pm Eastern on Thursday, May 7, 2009. Investors may listen to the live call by dialing 866-383-7998 (domestic) or617-597-5329 (international), passcode 32716473 five to ten minutes ahead of thestart of the call.
